参考文献/References:
[1] 徐婧.国家医疗保障局、国家中医药管理局联合发文推动医保支持中医药传承创新发展[J].中医药管理杂志,2022,30(1):176.
[2] 孙立明.关于中医优势病种研究的评述和建议[J].中华中医药杂志,2022,37(3):1271-1273.
[3] 陶群山,魏骅.安徽省中医药按病种支付方式改革效果分析[J].锦州医科大学学报(社会科学版),2019,17(6):25-31.
[4] 周倜,段涵敏,欧阳振华,等.看病住院“一口价”打包支付[N].湖南日报,2022-03-11(006).
[5] Wang Jianjian,Zheng Mingfu,Guo Qiangqiang,et al.Dominant diseases of Traditional Chinese Medicine (TCM)[J].Integrative Med-
icine Research,2022,11(3):100872.
[6] 张弘,丁科,谢俊明,等.“疗效价值付费”下的中医优势病种DRG付费方案探索[J].卫生经济研究,2021,38(12):75-76,79.
[7] 刘应科,孙光荣.中医优势病种的认识及发展建议[J].湖南中医药大学学报,2022,42(3):498-503.
[8] Liu Hongliang,Tan Jinpeng,Jon Kyongson,et al.A new case-mix classification method for mdical insurance payment[J].Mathematics,2022,10(10):1640.
[9] 张永硕,乔学斌.DRG-PPS在我国地方性卫生支付方式改革中的应用研究[J].江苏卫生事业管理,2022,33(7):841-843,866.
[10] 王静,钟力炜,言行,等.上海市中医医院医保支付改革实践探索[J].中国医院管理,2022,42(3):70-73.
[11] 沈洁,冯煜,汤哲伟,等.基于病案首页分析的中医医院单病种质量评价研究[J].中国医院管理,2022,42(5):42-46.
[12] 龚煜,许斯略,吴婧文,等.眉山市DRG付费“线上+线下”监管模式的探讨[J].中国医疗保险,2022(4):53-58.
相似文献/References:
[1]宋生来,胡小波,胡晓彦.湖州市医共体综合付费方式改革的经验和启示——以德清县为例[J].卫生经济研究,2021,38(12):25.
SONG Sheng-lai,HU Xiao-bo,HU Xiao-yan.Experience and Enlightenment of Comprehensive Payment Method Reform in Huzhou Medical Alliance——Taking Deqing County as Example[J].Journal Press of Health Economics Research,2021,38(10):25.
[2]陈其根,周晗彬,李伟峰,等.DRG点数法推进医保精细化管理的实证研究——以浙江省嘉兴市为例[J].卫生经济研究,2021,38(12):29.
CHEN Qi-gen,ZHOU Han-bin,LI Wei-feng,et al.An Empirical Study on Promoting Fine Management of Medical Insurance by DRG Point Method——Taking Jiaxing City, Zhejiang Province as an Example[J].Journal Press of Health Economics Research,2021,38(10):29.
[3]陈芬芳,姜建琼,韦庆钢,等.DRG下长期住院病例按床日点数付费的实践探索[J].卫生经济研究,2021,38(12):51.
CHEN Fen-fang,JIANG Jian-qiong,WEI Qing-gang,et al.Practical Exploration of Long-term Hospitalized Cases under DRG Per-diem Payment[J].Journal Press of Health Economics Research,2021,38(10):51.
[4]张 弘,丁 科,谢俊明,等.“疗效价值付费”下的中医优势病种DRG付费方案探索[J].卫生经济研究,2021,38(12):75.
ZHANG Hong,DING Ke,XIE Jun-ming,et al.Exploration of DRG Payment Scheme for Dominant Diseases of Traditional Chinese Medicine under "Efficacy Value Payment"[J].Journal Press of Health Economics Research,2021,38(10):75.
[5]黄成凤,申丽君,杨燕绥.价值导向型医保付费政策效果探讨——基于柳州市中医优势病种的实证分析[J].卫生经济研究,2022,39(5):37.
HUANG Cheng-feng,SHEN Li-jun,YANG Yan-sui.Discussion on the Effect of Value-Oriented Medical Insurance Payment Policy ——Based on Empirical Analysis in Liuzhou[J].Journal Press of Health Economics Research,2022,39(10):37.
[6]熊 蔓,伍林生.重庆市DRG实施成效评估及问题分析——基于模拟运行阶段[J].卫生经济研究,2022,39(7):28.
XIONG Man,WU Linsheng.Evaluation of Implementation Effectiveness and Problem Analysis of DRG in Chongqing ——Based on Simulation Operation Phase[J].Journal Press of Health Economics Research,2022,39(10):28.
[7]廖藏宜,秦纪华,蓝志成.中医优势病种按疗效价值付费的柳州经验[J].卫生经济研究,2023,40(6):61.
LIAO Zangyi,QIN Jihua,LAN Zhicheng.Experience of Efficacy Value Payment for Dominant Diseases of Traditional Chinese Medicine in Liuzhou[J].Journal Press of Health Economics Research,2023,40(10):61.
[8]杨 菁,李梦滢,沈际勇.中医优势病种支付方式改革试点经验与启示[J].卫生经济研究,2023,40(12):33.
YANG Jing,LI Mengying,SHEN Jiyong.Experience and Enlightenment of the Pilot Reform of Payment Methods for Dominant Diseases of Traditional Chinese Medicine[J].Journal Press of Health Economics Research,2023,40(10):33.
[9]牛 琨,贺 婷,袁 勇.按病种分值付费背景下医院科室收入核算模式探索[J].卫生经济研究,2024,41(02):85.
NIU Kun,HE Ting,YUAN Yong.Exploration on Revenue Accounting Model for Hospital Departments under the Background of Diagnosis-Intervention Packet[J].Journal Press of Health Economics Research,2024,41(10):85.
[10]岳铭坤,李 凯,黄 娜,等.按病种付费对中医优势病种住院费用的影响研究
——基于PSM-DID法[J].卫生经济研究,2024,41(03):62.
YUE Mingkun,LI Kai,HUANG Na,et al.Study the Impact of DRG on the Hospitalization Expenses of the Dominant Diseases of Traditional Chinese Medicine
——Based on PSM-DID Method[J].Journal Press of Health Economics Research,2024,41(10):62.
[11]李 希,邓世虎,彭美华,等.中医优势病种DRG付费:政策、难点及对策[J].卫生经济研究,2025,42(01):39.
LI Xi,DENG Shihu,PENG Meihua,et al.DRG Payment for Dominant Diseases of Traditional Chinese Medicine: Policies, Difficulties and Countermeasures[J].Journal Press of Health Economics Research,2025,42(10):39.